know your myeloma immunotherapy: teclistamab and other bispecifics
Published 1 year ago • 1.4K plays • Length 58:00
Download video MP4
Download video MP3
Similar videos
-
57:20
know your myeloma immunotherapy: bispecific antibodies with dr. cesar rodriguez
-
0:55
immunotherapy in multiple myeloma #knowmyeloma
-
14:31
teclistamab - guest lecture
-
22:21
tecvayli (teclistamab) everything you need to know
-
7:40
results of bispecific antibody combination in advanced myeloma | yael cohen, md | asco 2023
-
2:33
teclistamab approval for multiple myeloma treatment | ross firestone, md, phd | asco 2023
-
7:25
updated phase 1 results of teclistamab, a bcma × cd3 bispecific antibody, in rrmm
-
9:57
teclistamab, a bcma × cd3 bispecific antibody, in pts with rrmm: updated phase 1 results
-
56:40
immunotherapy 101 for multiple myeloma patients
-
3:34
predictors of delayed responses to teclistamab in myeloma | rahul banerjee, md | ims 2024
-
1:14:09
healthtree podcast for multiple myeloma: teclistamab's approval with dr. garfall
-
57:49
know your myeloma therapy: what's available for maintenance therapy?
-
14:00
what are bispecific antibodies? #myeloma
-
1:00
multiple myeloma - signs and symptoms #myeloma #cancer
-
11:35
what are myeloma targets? #myeloma
-
6:49
an update on the use of bispecific antibodies in myeloma | mohamad mohty, md | ims 2024
-
8:12
evaluating teclistamab in relapsed and/or refractory multiple myeloma
-
28:38
mcrt webinar may 2020: immunotherapies for myeloma - dr. nina shah
-
6:39
real world experiences of patients treated with teclistamab | shonali midha, md | ims 2023
Clip.africa.com - Privacy-policy